Security key
G2161P140
China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC)
CUSIP: G2161P140
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common stock, $0.08 par value
- Total 13F shares
- 2,870
- Share change
- -6,300
- Total reported value
- $3,186
- Price per share
- $1.62
- Number of holders
- 3
- Value change
- -$10,232
- Number of buys
- 1
- Number of sells
- 1
Report period
Q1 2024
Institutions
3
Top holders
3
SXTC full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
China SXT Pharmaceuticals, Inc. SEC filings
China SXT Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G2161P140
Recent filing periods:
Top shareholders of SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Marex Group plc |
13F
|
Company |
—
class O/S missing
|
41,293
|
$163,933 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
6,408
|
$25,440 | — | 31 Dec 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
2,759
|
$10,000 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
—
class O/S missing
|
3
|
$12 | — | 31 Dec 2023 | |
| Feng Felix Zhou |
3/4/5
|
Co-CEO and Director, Director |
—
class O/S missing
|
4
|
— | — | 04 Jul 2017 |
Institutional Holders of China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) as of Q1 2024
As of 31 Mar 2024,
China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,870 shares.
The largest 3 holders included
ACADIAN ASSET MANAGEMENT LLC, Qube Research & Technologies Ltd, and UBS Group AG.
This page lists
3
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
3
Q1 2024 holders
3
Holder diff
0
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.